{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:51:53Z","timestamp":1777891913278,"version":"3.51.4"},"reference-count":305,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1093\/ejcts\/ezx325","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T15:11:54Z","timestamp":1502896314000},"page":"79-111","source":"Crossref","is-referenced-by-count":344,"title":["2017 EACTS\/EACTA Guidelines on patient blood management for adult cardiac surgery"],"prefix":"10.1093","volume":"53","author":[{"given":"Domenico","family":"Pagano","sequence":"first","affiliation":[]},{"given":"Milan","family":"Milojevic","sequence":"additional","affiliation":[]},{"given":"Michael I","family":"Meesters","sequence":"additional","affiliation":[{"name":"Representing the EACTA"}]},{"given":"Umberto","family":"Benedetto","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Bolliger","sequence":"additional","affiliation":[{"name":"Representing the EACTA"}]},{"given":"Christian","family":"von Heymann","sequence":"additional","affiliation":[{"name":"Representing the EACTA"}]},{"given":"Anders","family":"Jeppsson","sequence":"additional","affiliation":[]},{"given":"Andreas","family":"Koster","sequence":"additional","affiliation":[{"name":"Representing the EACTA"}]},{"given":"Ruben L","family":"Osnabrugge","sequence":"additional","affiliation":[]},{"given":"Marco","family":"Ranucci","sequence":"additional","affiliation":[{"name":"Representing the EACTA"}]},{"given":"Hanne Berg","family":"Ravn","sequence":"additional","affiliation":[{"name":"Representing the EACTA"}]},{"given":"Alexander B A","family":"Vonk","sequence":"additional","affiliation":[]},{"given":"Alexander","family":"Wahba","sequence":"additional","affiliation":[]},{"given":"Christa","family":"Boer","sequence":"additional","affiliation":[{"name":"Representing the EACTA"}]}],"member":"286","published-online":{"date-parts":[[2017,10,3]]},"reference":[{"key":"2025110203543082600_ezx325-B1","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1537-2995.2004.04144.x","article-title":"The independent association of massive blood loss with mortality in cardiac surgery","volume":"44","author":"Karkouti","year":"2004","journal-title":"Transfusion"},{"key":"2025110203543082600_ezx325-B2","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.athoracsur.2008.07.114","article-title":"Surgical reexploration after cardiac operations: why a worse outcome?","volume":"86","author":"Ranucci","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.athoracsur.2013.07.020","article-title":"Transfusion of 1 and 2 units of red blood cells is associated with increased morbidity and mortality","volume":"97","author":"Paone","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.athoracsur.2016.01.006","article-title":"Reexploration for bleeding and its association with mortality after cardiac surgery","volume":"102","author":"Frojd","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B5","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.111.060871","article-title":"Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention","volume":"125","author":"Ndrepepa","year":"2012","journal-title":"Circulation"},{"key":"2025110203543082600_ezx325-B6","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials. A Consensus Report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"2025110203543082600_ezx325-B7","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1537-2995.2006.00860.x","article-title":"Development and validation of Transfusion Risk Understanding Scoring Tool (TRUST) to stratify cardiac surgery patients according to their blood transfusion needs","volume":"46","author":"Alghamdi","year":"2006","journal-title":"Transfusion"},{"key":"2025110203543082600_ezx325-B8","doi-asserted-by":"crossref","first-page":"249.e1","DOI":"10.1016\/j.jtcvs.2011.04.007","article-title":"Patient blood management during cardiac surgery: do we have enough evidence for clinical practice?","volume":"142","author":"Ranucci","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B9","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.athoracsur.2010.11.078","article-title":"2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines","volume":"91","author":"Ferraris","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/bja\/aeu483","article-title":"Risk scores to facilitate preoperative prediction of transfusion and large volume blood transfusion associated with adult cardiac surgery","volume":"114","author":"Goudie","year":"2015","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ejcts.2010.10.003","article-title":"The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding","volume":"39","author":"Vuylsteke","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203543082600_ezx325-B12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/BF03022795","article-title":"Prediction of massive blood transfusion in cardiac surgery","volume":"53","author":"Karkouti","year":"2006","journal-title":"Can J Anesth"},{"key":"2025110203543082600_ezx325-B13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/vox.12163","article-title":"Transfusion indication predictive score: a proposed risk stratification score for perioperative red blood cell transfusion in cardiac surgery","volume":"107","author":"Al-Khabori","year":"2014","journal-title":"Vox Sang"},{"key":"2025110203543082600_ezx325-B14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1160\/TH16-09-0721","article-title":"Prediction of severe bleeding after coronary surgery: the WILL-BLEED Risk Score","volume":"117","author":"Biancari","year":"2017","journal-title":"Thromb Haemost"},{"key":"2025110203543082600_ezx325-B15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1423-0410.2009.01160.x","article-title":"Predicting transfusions in cardiac surgery: the easier, the better: the Transfusion Risk and Clinical Knowledge score","volume":"96","author":"Ranucci","year":"2009","journal-title":"Vox Sang"},{"key":"2025110203543082600_ezx325-B16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/EJA.0000000000000630","article-title":"Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016","volume":"34","author":"Kozek-Langenecker","year":"2017","journal-title":"Eur J Anaesthesiol"},{"key":"2025110203543082600_ezx325-B17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/ALN.0000000000000463","article-title":"Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management","volume":"122","author":"American Society of Anesthesiologists Task Force on Perioperative Blood Management","year":"2015","journal-title":"Anesthesiology"},{"key":"2025110203543082600_ezx325-B18","first-page":"809","article-title":"Methodology manual for European Association for Cardio-Thoracic Surgery (EACTS) clinical guidelines","volume":"48","author":"Sousa-Uva","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203543082600_ezx325-B19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.2042-7174.1996.tb00844.x","article-title":"The Delphi and nominal group techniques in health services research","volume":"4","author":"Cantrill","year":"1996","journal-title":"Int J Pharm Pract"},{"key":"2025110203543082600_ezx325-B20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCINTERVENTIONS.111.967208","article-title":"Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study","volume":"5","author":"Mahla","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203543082600_ezx325-B21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/bja\/aew189","article-title":"Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study","volume":"117","author":"Malm","year":"2016","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B22","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.athoracsur.2016.05.003","article-title":"Does platelet reactivity predict bleeding in patients needing urgent coronary artery bypass grafting during dual antiplatelet therapy?","volume":"102","author":"Mahla","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1160\/TH04-12-0799","article-title":"Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery","volume":"93","author":"Blome","year":"2005","journal-title":"Thromb Haemost"},{"key":"2025110203543082600_ezx325-B24","doi-asserted-by":"crossref","first-page":"154.","DOI":"10.1186\/1749-8090-8-154","article-title":"Preoperative thrombin generation is predictive for the risk of blood loss after cardiac surgery: a research article","volume":"8","author":"Bosch","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"2025110203543082600_ezx325-B25","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1537-2995.2008.01827.x","article-title":"Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study","volume":"48","author":"Karlsson","year":"2008","journal-title":"Transfusion"},{"key":"2025110203543082600_ezx325-B26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/aas.12469","article-title":"Pre-operative fibrinogen supplementation in cardiac surgery patients: an evaluation of different trigger values","volume":"59","author":"Ranucci","year":"2015","journal-title":"Acta Anaesthesiol Scand"},{"key":"2025110203543082600_ezx325-B27","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.athoracsur.2013.11.064","article-title":"Low preoperative fibrinogen plasma concentration is associated with excessive bleeding after cardiac operations","volume":"97","author":"Walden","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/icvts\/ivt506","article-title":"The effects of pre- and postoperative fibrinogen levels on blood loss after cardiac surgery: a systematic review and meta-analysis","volume":"18","author":"Gielen","year":"2014","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203543082600_ezx325-B29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1538-7836.2010.04146.x","article-title":"Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleeding","volume":"9","author":"Coakley","year":"2011","journal-title":"J Thromb Haemost"},{"key":"2025110203543082600_ezx325-B30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MBC.0b013e3282f3f9d4","article-title":"The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass","volume":"19","author":"Reinh\u00f6fer","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2025110203543082600_ezx325-B31","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11239-013-0868-1","article-title":"Bleeding risk assessment using whole blood impedance aggregometry and rotational thromboelastometry in patients following cardiac surgery","volume":"36","author":"Petricevic","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"2025110203543082600_ezx325-B32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.athoracsur.2010.09.022","article-title":"Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines","volume":"91","author":"Ranucci","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B33","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/bja\/aeu315","article-title":"Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery","volume":"113","author":"Ranucci","year":"2014","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B34","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa020798","article-title":"Aspirin and mortality from coronary bypass surgery","volume":"347","author":"Mangano","year":"2002","journal-title":"N Engl J Med"},{"key":"2025110203543082600_ezx325-B35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1569-9293(03)00181-6","article-title":"Does aspirin 6\u2009h after coronary artery bypass grafting optimise graft patency?","volume":"2","author":"Musleh","year":"2003","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203543082600_ezx325-B36","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jacc.2012.03.030","article-title":"Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis","volume":"60","author":"Smith","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203543082600_ezx325-B37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/eurheartj\/ehv381","article-title":"Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study","volume":"37","author":"Hansson","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203543082600_ezx325-B38","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jamacardio.2016.3028","article-title":"Safety of preoperative use of ticagrelor with or without aspirin compared with aspirin alone in patients with acute coronary syndromes undergoing coronary artery bypass grafting","volume":"1","author":"Gherli","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2025110203543082600_ezx325-B39","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203543082600_ezx325-B40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-146-3-200702060-00007","article-title":"Brief communication: preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin","volume":"146","author":"O'Donnell","year":"2007","journal-title":"Ann Intern Med"},{"key":"2025110203543082600_ezx325-B41","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0022-5223(03)01324-2","article-title":"Preoperative use of enoxaparin is not a risk factor for postoperative bleeding after coronary artery bypass surgery","volume":"126","author":"Medalion","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3109\/14017430903388334","article-title":"Fondaparinux or enoxaparin: a comparative study of postoperative bleeding in coronary artery bypass grafting surgery","volume":"44","author":"Landenhed","year":"2010","journal-title":"Scand Cardiovasc J"},{"key":"2025110203543082600_ezx325-B43","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1538-7836.2006.01908.x","article-title":"Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry","volume":"4","author":"Spyropoulos","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2025110203543082600_ezx325-B44","first-page":"I19","article-title":"Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open-heart surgery in patients who present with an acute coronary syndrome: clinical investigation and reports","volume":"106(12 Suppl 1)","author":"Jones","year":"2002","journal-title":"Circulation"},{"key":"2025110203543082600_ezx325-B45","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.amjcard.2008.05.042","article-title":"Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry)","volume":"102","author":"Spyropoulos","year":"2008","journal-title":"Am J Cardiol"},{"key":"2025110203543082600_ezx325-B46","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/archinte.164.12.1319","article-title":"Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen","volume":"164","author":"Douketis","year":"2004","journal-title":"Arch Intern Med"},{"key":"2025110203543082600_ezx325-B47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists Collaboration","year":"2002","journal-title":"Br Med J"},{"key":"2025110203543082600_ezx325-B48","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/bja\/aev164","article-title":"Aspirin and coronary artery surgery: a systematic review and meta-analysis","volume":"115","author":"Hastings","year":"2015","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B49","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/eurheartj\/ehn104","article-title":"The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies","volume":"29","author":"Sun","year":"2008","journal-title":"Eur Heart J"},{"key":"2025110203543082600_ezx325-B50","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1056\/NEJMoa1507688","article-title":"Stopping vs. continuing aspirin before coronary artery surgery","volume":"374","author":"Myles","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203543082600_ezx325-B51","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jtcvs.2012.04.004","article-title":"Effects of preoperative aspirin in coronary artery bypass grafting: a double-blind, placebo-controlled, randomized trial","volume":"144","author":"Deja","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B52","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jtcvs.2005.02.041","article-title":"Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: role of aspirin and platelet glycoprotein IIIa polymorphism","volume":"130","author":"Morawski","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B53","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/bja\/aet339","article-title":"Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor","volume":"112","author":"Hansson","year":"2014","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/EJA.0000000000000348","article-title":"The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: an in-vitro study","volume":"33","author":"Martin","year":"2016","journal-title":"Eur J Anaesthesiol"},{"key":"2025110203543082600_ezx325-B55","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"2025110203543082600_ezx325-B56","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203543082600_ezx325-B57","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"2025110203543082600_ezx325-B58","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/eurheartj\/ehr422","article-title":"Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"32","author":"Becker","year":"2011","journal-title":"Eur Heart J"},{"key":"2025110203543082600_ezx325-B59","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease. A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025110203543082600_ezx325-B60","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pharmthera.2016.01.004","article-title":"Current status of data on cangrelor","volume":"159","author":"Qamar","year":"2016","journal-title":"Pharmacol Ther"},{"key":"2025110203543082600_ezx325-B61","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"key":"2025110203543082600_ezx325-B62","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial","volume":"57","author":"Held","year":"2011","journal-title":". J Am Coll Cardiol"},{"key":"2025110203543082600_ezx325-B63","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/ejcts\/ezw149","article-title":"Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment","volume":"50","author":"Tomsic","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203543082600_ezx325-B64","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1592\/phco.28.3.376","article-title":"Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting","volume":"28","author":"Pickard","year":"2008","journal-title":"Pharmacotherapy"},{"key":"2025110203543082600_ezx325-B65","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/hrt.2004.058396","article-title":"Does clopidogrel affect outcome after coronary artery bypass grafting? A meta-analysis","volume":"92","author":"Purkayastha","year":"2006","journal-title":"Heart"},{"key":"2025110203543082600_ezx325-B66","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/ejcts\/ezu366","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"46","author":"Kolh","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203543082600_ezx325-B67","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.athoracsur.2012.07.086","article-title":"2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations","volume":"94","author":"Ferraris","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B68","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/eurheartj\/ehp296","article-title":"P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use","volume":"30","author":"Wallentin","year":"2009","journal-title":"Eur Heart J"},{"key":"2025110203543082600_ezx325-B69","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"key":"2025110203543082600_ezx325-B70","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1538-7836.2011.04419.x","article-title":"Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses","volume":"9","author":"Storey","year":"2011","journal-title":"J Thromb Haemost"},{"key":"2025110203543082600_ezx325-B71","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.jacc.2010.03.108","article-title":"Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery","volume":"56","author":"Kwak","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025110203543082600_ezx325-B72","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/bja\/aep373","article-title":"Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of \u2032bridging\u2032 antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel","volume":"104","author":"Savonitto","year":"2010","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B73","doi-asserted-by":"crossref","first-page":"234S","DOI":"10.1378\/chest.126.3_suppl.234S","article-title":"Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Patrono","year":"2004","journal-title":"Chest"},{"key":"2025110203543082600_ezx325-B74","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1074248406299068","article-title":"Preoperative platelet inhibition with eptifibatide during coronary artery bypass grafting with cardiopulmonary bypass","volume":"12","author":"Dyke","year":"2007","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"2025110203543082600_ezx325-B75","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijcard.2007.02.005","article-title":"Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb\/IIIa receptor inhibitors","volume":"123","author":"De Carlo","year":"2008","journal-title":"Int J Cardiol"},{"key":"2025110203543082600_ezx325-B76","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijcard.2007.02.062","article-title":"CABG-procedures in patients with pretreatment with the GPIIb\/IIIa-receptor antagonist tirofiban (Aggrastat): modification of perioperative management?","volume":"127","author":"Boeken","year":"2008","journal-title":"Int J Cardiol"},{"key":"2025110203543082600_ezx325-B77","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0003-4975(03)00190-5","article-title":"Effects of preoperative enoxaparin versus unfractionated heparin on bleeding indices in patients undergoing coronary artery bypass grafting","volume":"76","author":"Kincaid","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B78","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.athoracsur.2014.01.077","article-title":"Type A aortic dissection in a patient on dabigatran: hemostasis post circulatory arrest","volume":"98","author":"Ashikhmina","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B79","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/aas.12303","article-title":"Dabigatran anticoagulation and Stanford type A aortic dissection: lethal coincidence: case report with literature review","volume":"58","author":"Stein","year":"2014","journal-title":"Acta Anaesthesiol Scand"},{"key":"2025110203543082600_ezx325-B80","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1053\/j.jvca.2015.10.017","article-title":"A case of fatal bleeding following emergency surgery on an ascending aorta intramural hematoma in a patient taking dabigatran","volume":"30","author":"Crapelli","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203543082600_ezx325-B81","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/trf.13027","article-title":"A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial","volume":"55","author":"Weltert","year":"2015","journal-title":"Transfusion"},{"key":"2025110203543082600_ezx325-B82","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jtcvs.2009.10.012","article-title":"Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study","volume":"139","author":"Weltert","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B83","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/ALN.0b013e318232004b","article-title":"Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery","volume":"115","author":"Yoo","year":"2011","journal-title":"Anesthesiology"},{"key":"2025110203543082600_ezx325-B84","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ejcts\/ezu200","article-title":"The impact of anaemia and intravenous iron replacement therapy on outcomes in cardiac surgery","volume":"47","author":"Hogan","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203543082600_ezx325-B85","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.athoracsur.2012.10.005","article-title":"Associations between preoperative anemia and outcomes after off-pump coronary artery bypass grafting","volume":"95","author":"Matsuda","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B86","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.athoracsur.2012.07.011","article-title":"Preoperative anemia does not increase the risks of early surgical revascularization after myocardial infarction","volume":"95","author":"Zhang","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B87","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.ajic.2016.03.027","article-title":"Risk factors for deep sternal wound infection after cardiac surgery: influence of red blood cell transfusions and chronic infection","volume":"44","author":"Cutrell","year":"2016","journal-title":"Am J Infect Control"},{"key":"2025110203543082600_ezx325-B88","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.athoracsur.2013.09.019","article-title":"The independent effects of anemia and transfusion on mortality after coronary artery bypass","volume":"97","author":"Engoren","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B89","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jtcvs.2016.06.010","article-title":"Does the severity of preoperative anemia or blood transfusion have a stronger impact on long-term survival after cardiac surgery?","volume":"152","author":"von Heymann","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B90","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/icvts\/ivs344","article-title":"The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial","volume":"15","author":"Garrido-Martin","year":"2012","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203543082600_ezx325-B91","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/vox.12278","article-title":"Intravenous iron isomaltoside 1000 (Monofer(R)) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial)","volume":"109","author":"Johansson","year":"2015","journal-title":"Vox Sang"},{"key":"2025110203543082600_ezx325-B92","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.106.653501","article-title":"Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery","volume":"116","author":"Kulier","year":"2007","journal-title":"Circulation"},{"key":"2025110203543082600_ezx325-B93","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCULATIONAHA.107.718353","article-title":"Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study","volume":"117","author":"Karkouti","year":"2008","journal-title":"Circulation"},{"key":"2025110203543082600_ezx325-B94","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/EJA.0b013e32835f4d5b","article-title":"Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology","volume":"30","author":"Kozek-Langenecker","year":"2013","journal-title":"Eur J Anaesthesiol"},{"key":"2025110203543082600_ezx325-B95","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/imi.0b013e3182747699","article-title":"Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011","volume":"7","author":"Menkis","year":"2012","journal-title":"Innovations (Phila)"},{"key":"2025110203543082600_ezx325-B96","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/ALN.0b013e3182475e39","article-title":"Advance targeted transfusion in anemic cardiac surgical patients for kidney protection: an unblinded randomized pilot clinical trial","volume":"116","author":"Karkouti","year":"2012","journal-title":"Anesthesiology"},{"key":"2025110203543082600_ezx325-B97","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/ejcts\/ezv268","article-title":"Current evidence of coronary artery bypass grafting off-pump versus on-pump: a systematic review with meta-analysis of over 16, 900 patients investigated in randomized controlled trialsdagger","volume":"49","author":"Deppe","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203543082600_ezx325-B98","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/imi.0000000000000184","article-title":"ISMICS consensus conference and statements of randomized controlled trials of off-pump versus conventional coronary artery bypass surgery","volume":"10","author":"Puskas","year":"2015","journal-title":"Innovations (Phila)"},{"key":"2025110203543082600_ezx325-B99","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijcard.2012.01.020","article-title":"Use of minimal extracorporeal circulation improves outcome after heart surgery; a systematic review and meta-analysis of randomized controlled trials","volume":"164","author":"Anastasiadis","year":"2013","journal-title":"Int J Cardiol"},{"key":"2025110203543082600_ezx325-B100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MAT.0b013e318209d63b","article-title":"Do miniaturized extracorporeal circuits confer significant clinical benefit without compromising safety? A meta-analysis of randomized controlled trials","volume":"57","author":"Harling","year":"2011","journal-title":"ASAIO J"},{"key":"2025110203543082600_ezx325-B101","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.jtcvs.2014.01.046","article-title":"Mitral valve surgery: right lateral minithoracotomy or sternotomy? A systematic review and meta-analysis","volume":"148","author":"Sundermann","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B102","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/imi.0b013e318216be5c","article-title":"Minimally invasive versus open mitral valve surgery: a consensus statement of the international society of minimally invasive coronary surgery (ISMICS) 2010","volume":"6","author":"Falk","year":"2011","journal-title":"Innovations (Phila)"},{"key":"2025110203543082600_ezx325-B103","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.athoracsur.2014.05.060","article-title":"A meta-analysis of minimally invasive versus conventional sternotomy for aortic valve replacement","volume":"98","author":"Phan","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B104","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/bjs.9877","article-title":"Multicentre randomized clinical trial to investigate the cost-effectiveness of an allogeneic single-donor fibrin sealant after coronary artery bypass grafting (FIBER Study)","volume":"102","author":"Tavilla","year":"2015","journal-title":"Br J Surg"},{"key":"2025110203543082600_ezx325-B105","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1200388","article-title":"Off-pump or on-pump coronary-artery bypass grafting at 30 days","volume":"366","author":"Lamy","year":"2012","journal-title":"N Engl J Med"},{"key":"2025110203543082600_ezx325-B106","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1211666","article-title":"Off-pump versus on-pump coronary-artery bypass grafting in elderly patients","volume":"368","author":"Diegeler","year":"2013","journal-title":"N Engl J Med"},{"key":"2025110203543082600_ezx325-B107","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/icvts\/ivv380","article-title":"Use of minimal invasive extracorporeal circulation in cardiac surgery: principles, definitions and potential benefits. A position paper from the Minimal invasive Extra-Corporeal Technologies international Society (MiECTiS)","volume":"22","author":"Anastasiadis","year":"2016","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203543082600_ezx325-B108","first-page":"CD004171","article-title":"Fibrin sealant use for minimising peri-operative allogeneic blood transfusion","volume":"2","author":"Carless","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203543082600_ezx325-B109","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12630-008-9038-x","article-title":"Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis","volume":"56","author":"Abrishami","year":"2009","journal-title":"Can J Anaesth"},{"key":"2025110203543082600_ezx325-B110","first-page":"D010562","article-title":"Topical application of tranexamic acid for the reduction of bleeding","volume":"7","author":"Ker","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203543082600_ezx325-B111","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/1076029613476338","article-title":"A randomized trial of the topical effect of antifibrinolytic epsilon aminocaproic Acid on coronary artery bypass surgery without cardiopulmonary bypass","volume":"20","author":"Gurian","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"2025110203543082600_ezx325-B112","first-page":"363","article-title":"Reduced transfusion requirements with a closed cardiopulmonary bypass system","volume":"49","author":"Casalino","year":"2008","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"2025110203543082600_ezx325-B113","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jtcvs.2010.07.024","article-title":"Cardiotomy suction, but not open venous reservoirs, activates coagulofibrinolysis in coronary artery surgery","volume":"141","author":"Nakahira","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B114","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.athoracsur.2008.09.076","article-title":"A systematic review of biocompatible cardiopulmonary bypass circuits and clinical outcome","volume":"87","author":"Ranucci","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1051\/ject\/201446197","article-title":"Attenuating the systemic inflammatory response to adult cardiopulmonary bypass: a critical review of the evidence base","volume":"46","author":"Landis","year":"2014","journal-title":"J Extra Corpor Technol"},{"key":"2025110203543082600_ezx325-B116","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/icvts\/ivr124","article-title":"Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit?","volume":"14","author":"Mahmood","year":"2012","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203543082600_ezx325-B117","first-page":"CD001888","article-title":"Cell salvage for minimising perioperative allogeneic blood transfusion","volume":"4","author":"Carless","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203543082600_ezx325-B118","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/0267659115613428","article-title":"Additional postoperative cell salvage of shed mediastinal blood in cardiac surgery does not reduce allogeneic blood transfusions: a cohort study","volume":"31","author":"Vermeijden","year":"2016","journal-title":"Perfusion"},{"key":"2025110203543082600_ezx325-B119","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1111\/trf.12126","article-title":"Intraoperative cell salvage is associated with reduced postoperative blood loss and transfusion requirements in cardiac surgery: a cohort study","volume":"53","author":"Vonk","year":"2013","journal-title":"Transfusion"},{"key":"2025110203543082600_ezx325-B120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/icvts\/ivu388","article-title":"Modified ultrafiltration in adult patients undergoing cardiac surgery","volume":"20","author":"Zakkar","year":"2015","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203543082600_ezx325-B121","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ejcts.2006.09.014","article-title":"Ultrafiltration reduces blood transfusions following cardiac surgery: a meta-analysis","volume":"30","author":"Boodhwani","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203543082600_ezx325-B122","doi-asserted-by":"crossref","first-page":"I253","DOI":"10.1161\/hc37t1.094931","article-title":"Modified ultrafiltration reduces morbidity after adult cardiac operations: a prospective, randomized clinical trial","volume":"104","author":"Luciani","year":"2001","journal-title":"Circulation"},{"key":"2025110203543082600_ezx325-B123","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/0267659112474861","article-title":"Effects of retrograde autologous priming on blood transfusion and clinical outcomes in adults: a meta-analysis","volume":"28","author":"Sun","year":"2013","journal-title":"Perfusion"},{"key":"2025110203543082600_ezx325-B124","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1510\/icvts.2008.195354","article-title":"Retrograde autologous priming and allogeneic blood transfusions: a meta-analysis","volume":"8","author":"Saczkowski","year":"2009","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203543082600_ezx325-B125","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/icvts\/ivt085","article-title":"The effect of retrograde autologous priming volume on haemodilution and transfusion requirements during cardiac surgery","volume":"16","author":"Vandewiele","year":"2013","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203543082600_ezx325-B126","first-page":"885","article-title":"Moderate-degree acidosis is an independent determinant of postoperative bleeding in cardiac surgery","volume":"81","author":"Ranucci","year":"2015","journal-title":"Minerva Anestesiol"},{"key":"2025110203543082600_ezx325-B127","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3349\/ymj.2014.55.1.224","article-title":"The influence of hypothermia on transfusion requirement in patients who received clopidogrel in proximity to off-pump coronary bypass surgery","volume":"55","author":"Lee","year":"2014","journal-title":"Yonsei Med J"},{"key":"2025110203543082600_ezx325-B128","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/MAT.0b013e31829f0e6e","article-title":"Effect of air exposure and suction on blood cell activation and hemolysis in an in vitro cardiotomy suction model","volume":"59","author":"El-Sabbagh","year":"2013","journal-title":"ASAIO J"},{"key":"2025110203543082600_ezx325-B129","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1213\/ane.0b013e3181875e2e","article-title":"Optimal perfusion during cardiopulmonary bypass: an evidence-based approach","volume":"108","author":"Murphy","year":"2009","journal-title":"Anesth Analg"},{"key":"2025110203543082600_ezx325-B130","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.athoracsur.2004.06.011","article-title":"A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients","volume":"78","author":"Lindholm","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B131","first-page":"277","article-title":"Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery","volume":"49","author":"Mirow","year":"2008","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"2025110203543082600_ezx325-B132","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1053\/j.jvca.2012.04.010","article-title":"A biocompatible cardiopulmonary bypass strategy to reduce hemostatic and inflammatory alterations: a randomized controlled trial","volume":"26","author":"Paparella","year":"2012","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203543082600_ezx325-B133","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1510\/icvts.2008.176479","article-title":"Effects of phosphorylcholine coating on extracorporeal circulation management and postoperative outcome: a double-blind randomized study","volume":"8","author":"Lorusso","year":"2008","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203543082600_ezx325-B134","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1051\/ject\/201244005","article-title":"Impact of a phosphorylcholine-coated cardiac bypass circuit on blood loss and platelet function: a prospective, randomized study","volume":"44","author":"Marguerite","year":"2012","journal-title":"J Extra Corpor Technol"},{"key":"2025110203543082600_ezx325-B135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10047-016-0887-8","article-title":"Poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit can reduce transfusion of platelet products compared to heparin-coated circuit during aortic arch surgery","volume":"19","author":"Hosoyama","year":"2016","journal-title":"J Artif Organs"},{"key":"2025110203543082600_ezx325-B136","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/0267659110392438","article-title":"Biocompatibility and pathways of initial complement pathway activation with Phisio- and PMEA-coated cardiopulmonary bypass circuits during open-heart surgery","volume":"26","author":"Thiara","year":"2011","journal-title":"Perfusion"},{"key":"2025110203543082600_ezx325-B137","first-page":"CD001888","article-title":"Cell salvage for minimising perioperative allogeneic blood transfusion","volume":"4","author":"Carless","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203543082600_ezx325-B138","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1213\/ane.0b013e3181aa084c","article-title":"The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials","volume":"109","author":"Wang","year":"2009","journal-title":"Anesth Analg"},{"key":"2025110203543082600_ezx325-B139","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1537-2995.2012.03836.x","article-title":"Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intra- and postoperative blood salvage strategy: results of a randomized comparison","volume":"53","author":"Weltert","year":"2013","journal-title":"Transfusion"},{"key":"2025110203543082600_ezx325-B140","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/icvts\/ivv355","article-title":"Intraoperative cell salvage during cardiac surgery is associated with reduced postoperative lung injury","volume":"22","author":"Engels","year":"2016","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203543082600_ezx325-B141","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/ejcts\/ezt019","article-title":"Cell salvage of cardiotomy suction blood improves the balance between pro- and anti-inflammatory cytokines after cardiac surgery","volume":"44","author":"Gabel","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203543082600_ezx325-B142","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.athoracsur.2010.02.003","article-title":"Cell saver for on-pump coronary operations reduces systemic inflammatory markers: a randomized trial","volume":"89","author":"Damgaard","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B143","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1010-7940(02)00834-5","article-title":"A prospective randomised comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery","volume":"23","author":"Jewell","year":"2003","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203543082600_ezx325-B144","doi-asserted-by":"crossref","first-page":"I89","DOI":"10.1161\/CIRCULATIONAHA.106.678987","article-title":"The cardiotomy trial: a randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function","volume":"116","author":"Rubens","year":"2007","journal-title":"Circulation"},{"key":"2025110203543082600_ezx325-B145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.transci.2015.03.019","article-title":"Discriminatory power of the intraoperative cell salvage use in the prediction of platelet and plasma transfusion in patients undergoing cardiac surgery","volume":"53","author":"Al-Khabori","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"2025110203543082600_ezx325-B146","doi-asserted-by":"crossref","first-page":"h5832.","DOI":"10.1136\/bmj.h5832","article-title":"Blood transfusion: summary of NICE guidance","volume":"351","author":"Padhi","year":"2015","journal-title":"Br Med J"},{"key":"2025110203543082600_ezx325-B147","first-page":"241","article-title":"Unwashed shed blood: should we transfuse it?","volume":"9","author":"Liumbruno","year":"2011","journal-title":"Blood Transfus"},{"key":"2025110203543082600_ezx325-B148","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/EJA.0b013e32833244c8","article-title":"Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion in small adults: a prospective, randomized trial","volume":"26","author":"Hou","year":"2009","journal-title":"Eur J Anaesthesiol"},{"key":"2025110203543082600_ezx325-B149","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jtcvs.2003.07.018","article-title":"Safety of deliberate intraoperative and postoperative hypothermia for patients undergoing coronary artery surgery: a randomized trial","volume":"127","author":"Nathan","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.jvca.2013.09.007","article-title":"Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery","volume":"28","author":"Vonk","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203543082600_ezx325-B151","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/0267659112436632","article-title":"Anticoagulation monitoring during extracorporeal circulation with the Hepcon\/HMS device","volume":"27","author":"Noui","year":"2012","journal-title":"Perfusion"},{"key":"2025110203543082600_ezx325-B152","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/jth.12999","article-title":"Anticoagulation management during multivessel coronary artery bypass grafting: a randomized trial comparing individualized heparin management and conventional hemostasis management","volume":"13","author":"Hoenicka","year":"2015","journal-title":"J Thromb Haemost"},{"key":"2025110203543082600_ezx325-B153","first-page":"123","article-title":"Blood loss after cardiopulmonary bypass, standard vs titrated protamine: a meta-analysis","volume":"71","author":"Wang","year":"2013","journal-title":"Neth J Med"},{"key":"2025110203543082600_ezx325-B154","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1160\/TH16-02-0117","article-title":"Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial","volume":"116","author":"Meesters","year":"2016","journal-title":"Thromb Haemost"},{"key":"2025110203543082600_ezx325-B155","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00000542-200502000-00007","article-title":"A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass","volume":"102","author":"Avidan","year":"2005","journal-title":"Anesthesiology"},{"key":"2025110203543082600_ezx325-B156","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jtcvs.2004.10.045","article-title":"Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass","volume":"130","author":"Avidan","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B157","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1213\/ANE.0b013e31827e4e62","article-title":"Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass","volume":"116","author":"Finley","year":"2013","journal-title":"Anesth Analg"},{"key":"2025110203543082600_ezx325-B158","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/0267659113483800","article-title":"Immediate effects of individualized heparin and protamine management on hemostatic activation and platelet function in adult patients undergoing cardiac surgery with tranexamic acid antifibrinolytic therapy","volume":"28","author":"Hofmann","year":"2013","journal-title":"Perfusion"},{"key":"2025110203543082600_ezx325-B159","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1510\/icvts.2006.133785","article-title":"Does use of the Hepcon point-of-care coagulation monitor to optimise heparin and protamine dosage for cardiopulmonary bypass decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery?","volume":"5","author":"Aziz","year":"2006","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203543082600_ezx325-B160","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/0267659106074770","article-title":"Anticoagulation management in patients undergoing open heart surgery by activated clotting time and whole blood heparin concentration","volume":"21","author":"Pappalardo","year":"2006","journal-title":"Perfusion"},{"key":"2025110203543082600_ezx325-B161","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/bja\/aeh037","article-title":"Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery","volume":"92","author":"Avidan","year":"2004","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B162","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.jvca.2007.07.011","article-title":"A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass","volume":"22","author":"Slight","year":"2008","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203543082600_ezx325-B163","doi-asserted-by":"crossref","first-page":"e0130271.","DOI":"10.1371\/journal.pone.0130271","article-title":"Heparin and protamine titration does not improve haemostasis after cardiac surgery: a prospective randomized study","volume":"10","author":"Radulovic","year":"2015","journal-title":"PLoS One"},{"key":"2025110203543082600_ezx325-B164","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jtcvs.2003.12.023","article-title":"Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?","volume":"128","author":"Teoh","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B165","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/1076029613484085","article-title":"Protamine overdose and its impact on coagulation, bleeding, and transfusions after cardiopulmonary bypass: results of a randomized double-blind controlled pilot study","volume":"20","author":"Koster","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"2025110203543082600_ezx325-B166","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00001721-200101000-00004","article-title":"Hemostatic effects of antithrombin III supplementation during cardiac surgery: results of a prospective randomized investigation","volume":"12","author":"Slaughter","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2025110203543082600_ezx325-B167","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jtcvs.2012.09.061","article-title":"Preoperative antithrombin supplementation in cardiac surgery: a randomized controlled trial","volume":"145","author":"Ranucci","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B168","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"key":"2025110203543082600_ezx325-B169","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1182\/blood-2013-10-533083","article-title":"Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin","volume":"123","author":"Warkentin","year":"2014","journal-title":"Blood"},{"key":"2025110203543082600_ezx325-B170","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/ajh.21032","article-title":"What is the potential for overdiagnosis of heparin-induced thrombocytopenia?","volume":"82","author":"Lo","year":"2007","journal-title":"Am J Hematol"},{"key":"2025110203543082600_ezx325-B171","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jtcvs.2005.10.049","article-title":"Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study","volume":"131","author":"Smedira","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B172","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.athoracsur.2007.04.007","article-title":"Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four\/heparin antibodies","volume":"84","author":"Dyke","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B173","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jtcvs.2005.09.057","article-title":"A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study","volume":"131","author":"Dyke","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B174","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.athoracsur.2006.09.038","article-title":"Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial","volume":"83","author":"Koster","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B175","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1160\/TH07-10-0644","article-title":"Bivalirudin","volume":"99","author":"Warkentin","year":"2008","journal-title":"Thromb Haemost"},{"key":"2025110203543082600_ezx325-B176","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ajh.24017","article-title":"Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin-induced thrombocytopenia-reactive antibodies or with true HIT (HIT-reactive antibodies plus thrombocytopenia): an 11-year experience","volume":"90","author":"Palatianos","year":"2015","journal-title":"Am J Hematol"},{"key":"2025110203543082600_ezx325-B177","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1067\/mtc.2001.118271","article-title":"One-year experience with the platelet glycoprotein IIb\/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II","volume":"122","author":"Koster","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B178","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1213\/ANE.0b013e3181c3c1cd","article-title":"Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia","volume":"110","author":"Welsby","year":"2010","journal-title":"Anesth Analg"},{"key":"2025110203543082600_ezx325-B179","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1182\/blood-2014-07-590844","article-title":"Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities","volume":"125","author":"Warkentin","year":"2015","journal-title":"Blood"},{"key":"2025110203543082600_ezx325-B180","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1111\/trf.12745","article-title":"Effects of a multimodality blood conservation schema toward improvement of intraoperative hemoglobin levels and off-pump transfusions in coronary artery bypass graft surgery","volume":"54","author":"Tran","year":"2014","journal-title":"Transfusion"},{"key":"2025110203543082600_ezx325-B181","doi-asserted-by":"crossref","first-page":"7.","DOI":"10.1186\/1749-8090-5-7","article-title":"Intra-operative intravenous fluid restriction reduces perioperative red blood cell transfusion in elective cardiac surgery, especially in transfusion-prone patients: a prospective, randomized controlled trial","volume":"5","author":"Vretzakis","year":"2010","journal-title":"J Cardiothorac Surg"},{"key":"2025110203543082600_ezx325-B182","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.athoracsur.2009.07.078","article-title":"Hematocrit on cardiopulmonary bypass and outcome after coronary surgery in nontransfused patients","volume":"89","author":"Ranucci","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B183","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.ejcts.2009.11.053","article-title":"Efficiency and safety of preoperative autologous blood donation in cardiac surgery: a matched-pair analysis in 432 patients","volume":"37","author":"Martin","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203543082600_ezx325-B184","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1053\/j.jvca.2005.04.017","article-title":"Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness","volume":"19","author":"Dietrich","year":"2005","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203543082600_ezx325-B185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.0958-7578.2004.0489.x","article-title":"Autologous transfusion techniques: a systematic review of their efficacy","volume":"14","author":"Carless","year":"2004","journal-title":"Transfus Med"},{"key":"2025110203543082600_ezx325-B186","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1213\/ANE.0000000000001609","article-title":"Acute normovolemic hemodilution reduces allogeneic red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis of randomized trials","volume":"124","author":"Barile","year":"2017","journal-title":"Anesth Analg"},{"key":"2025110203543082600_ezx325-B187","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/CCM.0000000000001479","article-title":"Effect of perioperative goal-directed hemodynamic resuscitation therapy on outcomes following cardiac surgery: a randomized clinical trial and systematic review","volume":"44","author":"Osawa","year":"2016","journal-title":"Crit Care Med"},{"key":"2025110203543082600_ezx325-B188","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/aas.12687","article-title":"Pressure-dependent changes in haematocrit and plasma volume during anaesthesia, a randomised clinical trial","volume":"60","author":"Damen","year":"2016","journal-title":"Acta Anaesthesiol Scand"},{"key":"2025110203543082600_ezx325-B189","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/ALN.0b013e31829bd770","article-title":"Individually optimized hemodynamic therapy reduces complications and length of stay in the intensive care unit: a prospective, randomized controlled trial","volume":"119","author":"Goepfert","year":"2013","journal-title":"Anesthesiology"},{"key":"2025110203543082600_ezx325-B190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1051\/ject\/201446293","article-title":"Influence of two colloidal extracorporeal primes on coagulation of cardiac surgical patients: a prospectively randomized open-label pilot trial","volume":"46","author":"Bethlehem","year":"2014","journal-title":"J Extra Corpor Technol"},{"key":"2025110203543082600_ezx325-B191","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3349\/ymj.2014.55.3.625","article-title":"Effect of 6% hydroxyethyl starch 130\/0.4 as a priming solution on coagulation and inflammation following complex heart surgery","volume":"55","author":"Cho","year":"2014","journal-title":"Yonsei Med J"},{"key":"2025110203543082600_ezx325-B192","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1213\/01.ANE.0000096006.60716.F6","article-title":"Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery","volume":"98","author":"Kuitunen","year":"2004","journal-title":"Anesth Analg"},{"key":"2025110203543082600_ezx325-B193","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/0267659114540022","article-title":"The use of balanced HES 130\/0.42 during complex cardiac surgery; effect on blood coagulation and fluid balance: a randomized controlled trial","volume":"30","author":"Schramko","year":"2015","journal-title":"Perfusion"},{"key":"2025110203543082600_ezx325-B194","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0267659113492836","article-title":"Human albumin in extracorporeal prime: effect on platelet function and bleeding","volume":"28","author":"Kamra","year":"2013","journal-title":"Perfusion"},{"key":"2025110203543082600_ezx325-B195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF03019102","article-title":"3.5% urea-linked gelatin is as effective as 6% HES 200\/0.5 for volume management in cardiac surgery patients","volume":"51","author":"Van der Linden","year":"2004","journal-title":"Can J Anesth"},{"key":"2025110203543082600_ezx325-B196","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00000542-200307000-00010","article-title":"Large-dose hydroxyethyl starch 130\/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200\/0.5 at recommended doses","volume":"99","author":"Kasper","year":"2003","journal-title":"Anesthesiology"},{"key":"2025110203543082600_ezx325-B197","doi-asserted-by":"crossref","first-page":"71.","DOI":"10.1186\/1749-8090-8-71","article-title":"Hydroxyethyl starch 6%, 130\/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study","volume":"8","author":"Gurbuz","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"2025110203543082600_ezx325-B198","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/0218492309338101","article-title":"Is 6% hydroxyethyl starch 130\/0.4 safe in coronary artery bypass graft surgery?","volume":"17","author":"Min","year":"2009","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"2025110203543082600_ezx325-B199","first-page":"91","article-title":"Hydroxyethyl starch 130\/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG","volume":"60","author":"Vanhoonacker","year":"2009","journal-title":"Acta Anaesthesiol Belg"},{"key":"2025110203543082600_ezx325-B200","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jtcvs.2009.02.035","article-title":"Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial","volume":"138","author":"Hecht-Dolnik","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B201","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1213\/01.ANE.0000175216.53374.27","article-title":"Hydroxyethyl starch 130\/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs","volume":"101","author":"Van der Linden","year":"2005","journal-title":"Anesth Analg"},{"key":"2025110203543082600_ezx325-B202","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/bja\/aet348","article-title":"Comparison of the effects of albumin 5%, hydroxyethyl starch 130\/0.4\u20096%, and Ringer's lactate on blood loss and coagulation after cardiac surgery","volume":"112","author":"Skhirtladze","year":"2014","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B203","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0003-4975(00)02393-6","article-title":"Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group","volume":"71","author":"DeFoe","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B204","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1540-8191.2005.00137.x","article-title":"Autologous blood transfusion in elective cardiac valve operations","volume":"20","author":"Lewis","year":"2005","journal-title":"J Card Surg"},{"key":"2025110203543082600_ezx325-B205","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1606424","article-title":"Tranexamic acid in patients undergoing coronary-artery surgery","volume":"376","author":"Myles","year":"2017","journal-title":"N Engl J Med"},{"key":"2025110203543082600_ezx325-B206","first-page":"CD001886","article-title":"Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion","volume":"3","author":"Henry","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203543082600_ezx325-B207","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jtcvs.2004.03.041","article-title":"Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials","volume":"128","author":"Sedrakyan","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B208","first-page":"CD007614","article-title":"Fresh frozen plasma for cardiovascular surgery","volume":"7","author":"Desborough","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203543082600_ezx325-B209","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2141.2004.04973.x","article-title":"Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials","volume":"126","author":"Stanworth","year":"2004","journal-title":"Br J Haematol"},{"key":"2025110203543082600_ezx325-B210","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2044.2004.03711.x","article-title":"The role of prophylactic fresh frozen plasma in decreasing blood loss and correcting coagulopathy in cardiac surgery. A systematic review","volume":"59","author":"Casbard","year":"2004","journal-title":"Anaesthesia"},{"key":"2025110203543082600_ezx325-B211","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1423-0410.2010.01339.x","article-title":"Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study","volume":"99","author":"Demeyere","year":"2010","journal-title":"Vox Sang"},{"key":"2025110203543082600_ezx325-B212","first-page":"CD010555","article-title":"Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients","volume":"7","author":"Johansen","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203543082600_ezx325-B213","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2005-872853","article-title":"Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation","volume":"54","author":"Godje","year":"2006","journal-title":"Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B214","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jtcvs.2013.04.044","article-title":"Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial","volume":"146","author":"Karkouti","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B215","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/jama.2016.21037","article-title":"Effect of fibrinogen concentrate on intraoperative blood loss among patients with intraoperative bleeding during high-risk cardiac surgery: a randomized clinical trial","volume":"317","author":"Bilecen","year":"2017","journal-title":"JAMA"},{"key":"2025110203543082600_ezx325-B216","first-page":"CD008864","article-title":"Fibrinogen concentrate in bleeding patients","volume":"8","author":"Wikkelso","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203543082600_ezx325-B217","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1053\/j.jvca.2013.02.009","article-title":"Transfusion of allogeneic blood products in proximal aortic surgery with hypothermic circulatory arrest: effect of thromboelastometry-guided transfusion management","volume":"27","author":"Fassl","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203543082600_ezx325-B218","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.jvca.2012.06.006","article-title":"Fibrinogen concentrate therapy in complex cardiac surgery","volume":"27","author":"Bilecen","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203543082600_ezx325-B219","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1213\/ANE.0000000000000689","article-title":"An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery","volume":"121","author":"Ortmann","year":"2015","journal-title":"Anesth Analg"},{"key":"2025110203543082600_ezx325-B220","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/ALN.0b013e3181f22b5a","article-title":"Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution","volume":"113","author":"Bolliger","year":"2010","journal-title":"Anesthesiology"},{"key":"2025110203543082600_ezx325-B221","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/aas.12740","article-title":"Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial","volume":"60","author":"Bignami","year":"2016","journal-title":"Acta Anaesthesiol Scand"},{"key":"2025110203543082600_ezx325-B222","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/icvts\/ivt491","article-title":"Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults","volume":"18","author":"Wademan","year":"2014","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203543082600_ezx325-B223","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.108.834275","article-title":"Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery","volume":"120","author":"Gill","year":"2009","journal-title":"Circulation"},{"key":"2025110203543082600_ezx325-B224","first-page":"CD005011","article-title":"Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia","volume":"3","author":"Simpson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203543082600_ezx325-B225","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.jvca.2010.08.012","article-title":"Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery: a systematic review and meta-analysis","volume":"25","author":"Adler Ma","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203543082600_ezx325-B226","doi-asserted-by":"crossref","first-page":"e3054.","DOI":"10.1136\/bmj.e3054","article-title":"Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis","volume":"344","author":"Ker","year":"2012","journal-title":"Br Med J"},{"key":"2025110203543082600_ezx325-B227","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/anae.12516","article-title":"The association between tranexamic acid and convulsive seizures after cardiac surgery: a multivariate analysis in 11\u2009529 patients","volume":"69","author":"Sharma","year":"2014","journal-title":"Anaesthesia"},{"key":"2025110203543082600_ezx325-B228","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/bja\/aes310","article-title":"Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome","volume":"110","author":"Koster","year":"2013","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B229","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1537-2995.2006.00724.x","article-title":"A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery","volume":"46","author":"Karkouti","year":"2006","journal-title":"Transfusion"},{"key":"2025110203543082600_ezx325-B230","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa051379","article-title":"The risk associated with aprotinin in cardiac surgery","volume":"354","author":"Mangano","year":"2006","journal-title":"N Engl J Med"},{"key":"2025110203543082600_ezx325-B231","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00134-013-3020-y","article-title":"Increased perioperative mortality following aprotinin withdrawal: a real-world analysis of blood management strategies in adult cardiac surgery","volume":"39","author":"Walkden","year":"2013","journal-title":"Intensive Care Med"},{"key":"2025110203543082600_ezx325-B232","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jtcvs.2012.07.018","article-title":"Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin","volume":"145","author":"Howell","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B233","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jtcvs.2007.11.045","article-title":"Bleeding in cardiac surgery: the use of aprotinin does not affect survival","volume":"135","author":"Pagano","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B234","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A comparison of aprotinin and lysine analogues in high-risk cardiac surgery","volume":"358","author":"Fergusson","year":"2008","journal-title":"N Engl J Med"},{"key":"2025110203543082600_ezx325-B235","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/bja\/aet008","article-title":"III. Aprotinin and cardiac surgery: a sorry tale of evidence misused","volume":"110","author":"McMullan","year":"2013","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B236","author":"Canada H"},{"key":"2025110203543082600_ezx325-B237","author":"Agency E"},{"key":"2025110203543082600_ezx325-B238","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/j.1537-2995.2011.03515.x","article-title":"Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials","volume":"52","author":"Yang","year":"2012","journal-title":"Transfusion"},{"key":"2025110203543082600_ezx325-B239","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1213\/ANE.0b013e3181db7991","article-title":"The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: a prospective observational study","volume":"110","author":"Karkouti","year":"2010","journal-title":"Anesth Analg"},{"key":"2025110203543082600_ezx325-B240","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1016\/j.thromres.2010.05.028","article-title":"Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: a prospective observational study","volume":"126","author":"Ternstrom","year":"2010","journal-title":"Thromb Res"},{"key":"2025110203543082600_ezx325-B241","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1160\/TH09-12-0858","article-title":"In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM)","volume":"104","author":"Theusinger","year":"2010","journal-title":"Thromb Haemost"},{"key":"2025110203543082600_ezx325-B242","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1213\/ANE.0b013e318292efa4","article-title":"The relationship between fibrinogen levels after cardiopulmonary bypass and large volume red cell transfusion in cardiac surgery: an observational study","volume":"117","author":"Karkouti","year":"2013","journal-title":"Anesth Analg"},{"key":"2025110203543082600_ezx325-B243","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1160\/TH08-12-0826","article-title":"Repletion of factor XIII following cardiopulmonary bypass using a recombinant A-subunit homodimer. A preliminary report","volume":"102","author":"Levy","year":"2009","journal-title":"Thromb Haemost"},{"key":"2025110203543082600_ezx325-B244","first-page":"360","article-title":"Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates","volume":"81","author":"Hiippala","year":"1995","journal-title":"Anesth Analg"},{"key":"2025110203543082600_ezx325-B245","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1537-2995.2009.02295.x","article-title":"Is preoperative fibrinogen predictive for postoperative bleeding after coronary artery bypass grafting surgery?","volume":"49","author":"Bolliger","year":"2009","journal-title":"Transfusion"},{"key":"2025110203543082600_ezx325-B246","doi-asserted-by":"crossref","first-page":"i35","DOI":"10.1093\/bja\/aet380","article-title":"Perioperative factor concentrate therapy","volume":"111(Suppl 1)","author":"Tanaka","year":"2013","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B247","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/bja\/aev367","article-title":"Preoperative supplementation with fibrinogen concentrate in cardiac surgery: a randomized controlled study","volume":"116","author":"Jeppsson","year":"2016","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B248","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/ALN.0b013e3182715d4d","article-title":"Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial","volume":"118","author":"Rahe-Meyer","year":"2013","journal-title":"Anesthesiology"},{"key":"2025110203543082600_ezx325-B249","doi-asserted-by":"crossref","first-page":"e002066.","DOI":"10.1161\/JAHA.115.002066","article-title":"Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery","volume":"4","author":"Ranucci","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2025110203543082600_ezx325-B250","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/bja\/aew169","article-title":"Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy","volume":"117","author":"Rahe-Meyer","year":"2016","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B251","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/bja\/aev539","article-title":"Fibrinogen supplementation after cardiac surgery: insights from the Zero-Plasma trial (ZEPLAST)","volume":"116","author":"Ranucci","year":"2016","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B252","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/bja\/aeu364","article-title":"Perioperative administration of fibrinogen does not increase adverse cardiac and thromboembolic events after cardiac surgery","volume":"114","author":"Fassl","year":"2015","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B253","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1213\/ANE.0000000000001188","article-title":"Prothrombin complex concentrates for bleeding in the perioperative setting","volume":"122","author":"Ghadimi","year":"2016","journal-title":"Anesth Analg"},{"key":"2025110203543082600_ezx325-B254","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/icvts\/ivs224","article-title":"Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery","volume":"15","author":"Arnekian","year":"2012","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203543082600_ezx325-B255","doi-asserted-by":"crossref","first-page":"5.","DOI":"10.1186\/s13054-015-1172-6","article-title":"Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery","volume":"20","author":"Cappabianca","year":"2016","journal-title":"Crit Care"},{"key":"2025110203543082600_ezx325-B256","first-page":"CD001884","article-title":"Desmopressin for minimising perioperative allogeneic blood transfusion","volume":"1","author":"Carless","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203543082600_ezx325-B257","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/ALN.0b013e31818db18b","article-title":"Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials","volume":"109","author":"Crescenzi","year":"2008","journal-title":"Anesthesiology"},{"key":"2025110203543082600_ezx325-B258","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/jth.13576","article-title":"Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Desborough","year":"2017","journal-title":"J Thromb Haemost"},{"key":"2025110203543082600_ezx325-B259","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1414219","article-title":"Effects of red-cell storage duration on patients undergoing cardiac surgery","volume":"372","author":"Steiner","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203543082600_ezx325-B260","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1500704","article-title":"Age of transfused blood in critically ill adults","volume":"372","author":"Lacroix","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203543082600_ezx325-B261","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/vox.12042","article-title":"Proteomic analysis of the supernatant of red blood cell units: the effects of storage and leucoreduction","volume":"105","author":"Dzieciatkowska","year":"2013","journal-title":"Vox Sang"},{"key":"2025110203543082600_ezx325-B262","author":"Membe","year":"2011"},{"key":"2025110203543082600_ezx325-B263","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jss.2016.03.008","article-title":"Point-of-care thromboelastography\/thromboelastometry-based coagulation management in cardiac surgery: a meta-analysis of 8332 patients","volume":"203","author":"Deppe","year":"2016","journal-title":"J Surg Res"},{"key":"2025110203543082600_ezx325-B264","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/bja\/aex100","article-title":"Routine use of viscoelastic blood tests for diagnosis and treatment of coagulopathic bleeding in cardiac surgery: updated systematic review and meta-analysis","volume":"118","author":"Serraino","year":"2017","journal-title":"Br J Anaesth"},{"key":"2025110203543082600_ezx325-B265","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/CIRCULATIONAHA.116.023956","article-title":"Point-of-care hemostatic testing in cardiac surgery: a stepped-wedge clustered randomized controlled trial","volume":"134","author":"Karkouti","year":"2016","journal-title":"Circulation"},{"key":"2025110203543082600_ezx325-B266","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1403612","article-title":"Liberal or restrictive transfusion after cardiac surgery","volume":"372","author":"Murphy","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203543082600_ezx325-B267","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1001\/jama.2010.1446","article-title":"Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial","volume":"304","author":"Hajjar","year":"2010","journal-title":"JAMA"},{"key":"2025110203543082600_ezx325-B268","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/cc4891","article-title":"The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for elective low risk coronary artery bypass graft surgery on oxygen delivery and clinical outcome\u2013a randomized controlled study [ISRCTN35655335]","volume":"10","author":"von Heymann","year":"2006","journal-title":"Crit Care"},{"key":"2025110203543082600_ezx325-B269","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.transci.2014.08.007","article-title":"Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients","volume":"51","author":"Klausen","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"2025110203543082600_ezx325-B270","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1423-0410.2010.01426.x","article-title":"Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century","volume":"100","author":"Dwyre","year":"2011","journal-title":"Vox Sang"},{"key":"2025110203543082600_ezx325-B271","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1182\/blood-2010-04-278135","article-title":"Transfusion-related acute lung injury: from bedside to bench and back","volume":"117","author":"Shaz","year":"2011","journal-title":"Blood"},{"key":"2025110203543082600_ezx325-B272","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/MOH.0000000000000187","article-title":"Current options for transfusion-related acute lung injury risk mitigation in platelet transfusions","volume":"22","author":"Dunbar","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"2025110203543082600_ezx325-B273","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.blre.2007.07.003","article-title":"Transfusion-related immunomodulation (TRIM): an update","volume":"21","author":"Vamvakas","year":"2007","journal-title":"Blood Rev"},{"key":"2025110203543082600_ezx325-B274","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1537-2995.2007.01158.x","article-title":"The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients","volume":"47","author":"Blumberg","year":"2007","journal-title":"Transfusion"},{"key":"2025110203543082600_ezx325-B275","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.2014.2726","article-title":"Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis","volume":"311","author":"Rohde","year":"2014","journal-title":"JAMA"},{"key":"2025110203543082600_ezx325-B276","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1161\/01.CIR.0000130162.11925.21","article-title":"Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery","volume":"109","author":"Bilgin","year":"2004","journal-title":"Circulation"},{"key":"2025110203543082600_ezx325-B277","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2015.8690","article-title":"Red blood cell concentrate storage and survival after cardiac surgery","volume":"314","author":"Sartipy","year":"2015","journal-title":"JAMA"},{"key":"2025110203543082600_ezx325-B278","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1182\/blood-2015-09-670950","article-title":"Transfusion of fresher vs older red blood cells in hospitalized patients: a systematic review and meta-analysis","volume":"127","author":"Alexander","year":"2016","journal-title":"Blood"},{"key":"2025110203543082600_ezx325-B279","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1111\/j.1537-2995.2009.02338.x","article-title":"Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks","volume":"49","author":"Vamvakas","year":"2009","journal-title":"Transfusion"},{"key":"2025110203543082600_ezx325-B280","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/j.1537-2995.2010.02747.x","article-title":"Storage age of transfused platelets and outcomes after cardiac surgery","volume":"50","author":"Welsby","year":"2010","journal-title":"Transfusion"},{"key":"2025110203543082600_ezx325-B281","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1213\/ANE.0b013e31824d523b","article-title":"The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry","volume":"115","author":"Ogawa","year":"2012","journal-title":"Anesth Analg"},{"key":"2025110203543082600_ezx325-B282","first-page":"CD007871","article-title":"Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding","volume":"8","author":"Wikkelso","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203543082600_ezx325-B283","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19580","article-title":"Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis","volume":"19","author":"Whiting","year":"2015","journal-title":"Health Technol Assess"},{"key":"2025110203543082600_ezx325-B284","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/ALN.0b013e318264c644","article-title":"Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients","volume":"117","author":"Weber","year":"2012","journal-title":"Anesthesiology"},{"key":"2025110203543082600_ezx325-B285","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.athoracsur.2013.12.025","article-title":"Safe application of a restrictive transfusion protocol in moderate-risk patients undergoing cardiac operations","volume":"97","author":"Song","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B286","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.athoracsur.2015.02.034","article-title":"Acute kidney injury and hemodilution during cardiopulmonary bypass: a changing scenario","volume":"100","author":"Ranucci","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"2025110203543082600_ezx325-B287","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S2352-3026(15)00198-2","article-title":"Indications for red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis","volume":"2","author":"Patel","year":"2015","journal-title":"Lancet Haematol"},{"key":"2025110203543082600_ezx325-B288","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jtcvs.2015.07.051","article-title":"A liberal strategy of red blood cell transfusion reduces cardiogenic shock in elderly patients undergoing cardiac surgery","volume":"150","author":"Nakamura","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B289","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/trf.12943","article-title":"Platelet transfusion: a systematic review of the clinical evidence","volume":"55","author":"Kumar","year":"2015","journal-title":"Transfusion"},{"key":"2025110203543082600_ezx325-B290","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"Platelet transfusion: a clinical practice guideline from the AABB","volume":"162","author":"Kaufman","year":"2015","journal-title":"Ann Intern Med"},{"key":"2025110203543082600_ezx325-B291","doi-asserted-by":"crossref","first-page":"S336","DOI":"10.1111\/jth.12963","article-title":"Extracorporeal life support: the precarious balance of hemostasis","volume":"13(Suppl 1)","author":"Annich","year":"2015","journal-title":"J Thromb Haemost"},{"key":"2025110203543082600_ezx325-B292","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/CIRCULATIONAHA.104.478222","article-title":"Coagulation assays","volume":"112","author":"Bates","year":"2005","journal-title":"Circulation"},{"key":"2025110203543082600_ezx325-B293","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1309\/AJCPR3JTOK7NKDBJ","article-title":"Pathology consultation on anticoagulation monitoring: factor X-related assays","volume":"140","author":"Wool","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"2025110203543082600_ezx325-B294","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1345\/aph.1R635","article-title":"Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin","volume":"47","author":"Price","year":"2013","journal-title":"Ann Pharmacother"},{"key":"2025110203543082600_ezx325-B295","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jchf.2014.11.009","article-title":"Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support","volume":"3","author":"Adatya","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2025110203543082600_ezx325-B296","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1213\/01.ANE.0000057605.61063.55","article-title":"An assessment of different filter systems for extracorporeal elimination of bivalirudin: an in vitro study","volume":"96","author":"Koster","year":"2003","journal-title":"Anesth Analg"},{"key":"2025110203543082600_ezx325-B297","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0035-1556873","article-title":"The munich lung transplant group: intraoperative extracorporeal circulation in lung transplantation","volume":"63","author":"Hoechter","year":"2015","journal-title":"Thorac Cardiovasc Surg"},{"key":"2025110203543082600_ezx325-B298","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1097\/PCC.0b013e31827127e4","article-title":"Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey","volume":"14","author":"Bembea","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"2025110203543082600_ezx325-B299","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00134-014-3574-3","article-title":"Quantitative measurement of heparin in comparison with conventional anticoagulation monitoring and the risk of thrombotic events in adults on extracorporeal membrane oxygenation","volume":"41","author":"Chu","year":"2015","journal-title":"Intensive Care Med"},{"key":"2025110203543082600_ezx325-B300","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1007\/s00134-015-4015-7","article-title":"Low-dose heparin during extracorporeal membrane oxygenation treatment in adults","volume":"41","author":"Yeo","year":"2015","journal-title":"Intensive Care Med"},{"key":"2025110203543082600_ezx325-B301","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MAT.0000000000000010","article-title":"Antithrombin III supplementation on extracorporeal membrane oxygenation: impact on heparin dose and circuit life","volume":"60","author":"Byrnes","year":"2014","journal-title":"ASAIO J"},{"key":"2025110203543082600_ezx325-B302","first-page":"858","article-title":"Coagulation monitoring in postcardiotomy ECMO: conventional tests, point-of-care, or both?","volume":"82","author":"Ranucci","year":"2016","journal-title":"Minerva Anestesiol"},{"key":"2025110203543082600_ezx325-B303","doi-asserted-by":"crossref","first-page":"R275.","DOI":"10.1186\/cc10556","article-title":"Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation","volume":"15","author":"Ranucci","year":"2011","journal-title":"Crit Care"},{"key":"2025110203543082600_ezx325-B304","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.jvca.2012.07.019","article-title":"Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study","volume":"27","author":"Pieri","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025110203543082600_ezx325-B305","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1525-1594.2007.00388.x","article-title":"Argatroban in extracorporeal membrane oxygenation","volume":"31","author":"Beiderlinden","year":"2007","journal-title":"Artif Organs"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/53\/1\/79\/64103043\/ejcts_53_1_79.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/53\/1\/79\/64103043\/ejcts_53_1_79.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T08:55:11Z","timestamp":1762073711000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/53\/1\/79\/4316171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,3]]},"references-count":305,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezx325","relation":{},"ISSN":["1010-7940","1873-734X"],"issn-type":[{"value":"1010-7940","type":"print"},{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,10,3]]}}}